cucurbitacins has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, C; Guo, J; Wang, J; Xing, T; Xu, H; Xu, J; Yu, H | 1 |
| Alshamsan, A; Kwon, GS; Lai, R; Lavasanifar, A; Ma, Z; Mahmud, A; Molavi, O; Samuel, J | 1 |
2 other study(ies) available for cucurbitacins and B16 Melanoma
| Article | Year |
|---|---|
The anti-melanoma efficiency of the intratumoral injection of cucurbitacin-loaded sustained release carriers: in situ-forming implants.
Topics: Animals; Cell Line, Tumor; Cucurbitacins; Drug Carriers; Drug Implants; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning | 2015 |
Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
Topics: Animals; Antineoplastic Agents; Benzene Derivatives; Biological Availability; Cell Line, Tumor; Cell Survival; Cucurbitacins; Drug Delivery Systems; Inhibitory Concentration 50; Lactones; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Micelles; Polyesters; Polyethylene Glycols; Polymers; Solubility; STAT3 Transcription Factor; Triterpenes | 2008 |